Maravai Lifesciences Holdings (MRVI) Retained Earnings (2020 - 2026)

Maravai Lifesciences Holdings' Retained Earnings history runs 7 years deep, the most recent figure standing at $466000.0 for Q1 2026.

• On a quarterly basis, Retained Earnings fell 99.75% year-over-year to $466000.0 in Q1 2026; TTM through Mar 2026 was $466000.0, a 99.75% decrease from a year earlier, with the FY2025 full-year figure at $524000.0, down 99.63% from the prior year.
• Retained Earnings eased to $466000.0 in Q1 2026 per MRVI's latest filing, from $524000.0 in the prior quarter.
• Across five years, Retained Earnings topped out at $404.8 million in Q4 2022 and bottomed at $466000.0 in Q1 2026.
• The 5-year median for Retained Earnings is $140.9 million (2024), against an average of $172.2 million.
• Across the five-year window, Retained Earnings jumped 401.77% in 2022 and plunged 99.75% in 2026, its largest moves.
• Year by year, Retained Earnings stood at $404.8 million in 2022, then plunged by 68.25% to $128.5 million in 2023, then rose by 9.64% to $140.9 million in 2024, then sank by 99.63% to $524000.0 in 2025, then fell by 11.07% to $466000.0 in 2026.
• Per Business Quant, the three latest MRVI Retained Earnings figures stand at $466000.0 (Q1 2026), $524000.0 (Q4 2025), and $579000.0 (Q3 2025).